2Lein M,Jung K,Hammerer P,et al. A multicenter clinical trial on the use of alphal-antichymotrypsin-prostalespecific antigen in prostate cancer diagnosis. Prostate.2001,47(2):77-84.
3Villena V,Echave-Sustaca J, Lopez-Encuentra A,et al. Determination of tissue polypeptide-speeifie antigen in pleural fluid and serum from patients with pleural effusion. Int J Biol Markers,1995,10(3):161-165.
4Ozyilkan O,Baltali E, Kirazli S. CA15 3,ceruloplasmin and tissue polypeptide specific antigen as a tumour marker panel in breast cancer. East Afr Med J. 2000,77 (6):291-294.
5Giovanella L,Ceriani L,Bandera M,et al. Tissue polypepride specific antigen (tps) and cytokeratin 19 fragment (CYFRA 21. 1) immunoradiometric assay in non small cell lung Cancer evaluation. QJ Nucl Med, 1995,39(4): 285-289.
6Ho YJ ,Hsieh JF ,Tasi SC ,et al. Tissue polypeptide specific antigen and squamous cell carcinoma antigen for early prediction of recurrence in lung squamous cell carcinoma. Lung,2000,178(2):75-80.
7Dejong S, Kooistra AJ, Deveries E, et al. Topoisomerase Ⅱ as a target of VM-26 and 4'-(9-Acridinylamino) meth-anesulfonmaniside in atypical multidrug resistant human small cell lung carcinoma cells[J]. Cancer Res, 1993, 53:1064-1067.
8Volm M, Bak M, Mattern J. Intrinsic drug resistance in a human lung carcinoma xenograft is associsted with overexpression of multidrug-resistance DNA-sequences and of plasma membrane glycoprotein[J ]. Arzneim Forsch Drug Res, 1988, 38(3): 1189.
9Gottesman MM, Pastan 1. The multidring transporter: a double edged sword[J]. J Biol Chem, 1988, 263:12163-12166.
10Batist G, Tulpule A, Sinha BK, et al. Overexpression of a novel anionic glutathione transerase in multi-resistant human breast cancercells[J]. J Biol chem, 1986, 261:15544-15549.
